Who speaks to whom in stem cell biology?

A contact list for embryonic stem cell proteins highlights development and disease genes as key nodes of the network

Who speaks to whom in stem cell biology?

stemcells.jpg
Regulatory network of targets of ESC transcription factors amongst Oct4 partners. Stem cell transcription factors and their target genes among Oct4-associated proteins are shown in dark and light grey, respectively. Oct4 and its regulatory targets are highlighted in blue.

A new study teases apart the vital conversations carried out by a key protein in early embryo development. The researchers have identified multiple interactions of the protein Oct4 with other proteins in embryonic stem cells: it's a Facebook of stem cell proteins.

Their work highlights that, in embryos, Oct4's interactions play an important role in orchestrating correct development: just as important, Oct4 and its partners play a continued role such that, in later life, the genes encoding them can be mutated into cancer-causing genes.

Embryonic stem (ES) cells are derived from embryos and maintain the essential early embryonic ability to develop into any of the tissues that become part of an adult. Adult cells, for the most part, cannot move from their determined path: they will ever be liver cells, or kidney cells, or whatever fate has decided.

To restore the ability to become more than one cell type - called pluripotency by biologists - is important to biology, to understanding development and to developing new treatments based on ES cells.

"There are a small number of proteins that research has shown play a critical role in the processes of successfully producing embryonic stem cells. Oct4 is one of these. The important question is how does it have its effects?"

"We have described an extended network of partners for Oct4 - almost 100 proteins -and discovered new partners that Oct4 talks to. Many are important not only in embryo development and in stem cell biology, but also is human disease. These are really exciting results."

Dr Jyoti Choudhary, leader of the Proteomic Mass Spectrometry team at the Wellcome Trust Sanger Institute

Oct4 is one of the proteins that plays a pivotal role in embryos - and can play a role in reprogramming cells into becoming pluripotent. It carries out its roles by talking to other proteins, through protein-protein interactions.

The team developed a new method, which could be widely applied, to look at which proteins are part of the cellular conversations of Oct4. They added a signal to an Oct4 gene that would tag the Oct4 protein for purification and reintroduced the modified gene into mouse cells in an extra copy, but keeping the endogenous regulation.

They then pulled Oct4 from cells along with the proteins with which it was associated.

For more than 80 per cent of Oct4's binding proteins, deletion leads to embryonic death, showing their partnership is important. At least half of the proteins are controlled by key regulators of development, suggesting roles for these in development as well.

Mouse partners of Oct4 and their human counterparts are more similar than the typical gene - their DNA sequence is 94 per cent identical - suggesting they play important and similar roles in the two species. Indeed, 14 Oct4 partners are linked with human disease: eight are known cancer-causing genes. Of the 14 genes, mutation in 13 in the mouse causes a change that closely resembles the human disease symptoms.

"We have found the contact list, seen who talks to whom and picked out the key members of the group. This approach can be widely used, giving us a systems biology description of protein interactions. This will be a driver in understanding embryo and stem cell biology and in examining human disease."

Dr Mercedes Pardo, first author on the study

Notes to Editors
Publications
  • An expanded Oct4 interaction network: implications for stem cell biology, development, and disease.

    Pardo M, Lang B, Yu L, Prosser H, Bradley A et al.

    Cell stem cell 2010;6;4;382-95

Funding

This work was supported by the Wellcome Trust and the Herchel Smith Research Studentship Fund

Participating Centres
  • Proteomic Mass Spectrometry. Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom
  • Mouse Genomics, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom
  • MRC Laboratory of Molecular Biology, Cambridge, United Kingdom
Selected Websites
Contact the Press Office

Emily Mobley, Media Manager

Tel +44 (0)1223 496 851

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Dr Matthew Midgley, Media Officer

Tel +44 (0)1223 494 856

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7748 379849

Recent News

Appointments and changes to the Genome Research Limited Board
At the GRL Board meeting on 2 December 2019, David Willetts announced his intention to step down as Chair because of his extensive commitments across the academic and science sectors. Wellcome's Director, Jeremy Farrar, will take over the Chair of GRL Board from 1 January 2020.
Researchers identify new possibilities for the treatment of inflammatory bowel disease
Two molecular pathways found to be integral to maintaining balance in the digestive system
Root of childhood kidney cancer discovered
Pre-cancerous signatures found in healthy tissue point the way towards new treatment options